Dynamiker Biotechnology(Tianjin)Co., Ltd is a comprehensive biomedical national high-tech enterprise, built by Dr. Zeqi Zhou from Harvard Medical School, who is rewarded as Biomedical Talent of Jing-Jin-Ji. Established in March 2014, Dynamiker is dedicated to R&D, production, clinical application and technical service of Invasive Fungal Disease (IFD) diagnosis. With the mission of building international renowned brand for early and rapid IVD products for IFD, Dynamiker has become the global leader in IFD diagnosis.
With its headquarters in Sino-Singapore Tianjin Eco-City, Dynamiker has established an international R&D and Production base, which is accredited by ISO13485. Dynamiker has won numbers of prizes like “National High-tech Enterprise”, “ Top 10 of The Forth China Innovation & Enterpreneurship Competition”, “Key Overseas Chinese Entrepreneurial Team Of The State Council”, “National 12th Five - Year Science and Technology Innovation Outstanding Contribution Award”, “ MOLSS the Most Promising Overseas Students Venture Company”, “Tianjin First Leading Enterprises Of Emerging Industry”, “the Second Prize of Tianjin Advanced Science and Technology”, “National Model Academician And Expert Workstation” and etc.
The core team of Dynamiker, including more than 10 doctors and 30 masters, are all from famous biopharmaceutical companies or tertiary hospitals, and have rich experience in R&D, management, production and technology application. With its key core technologies and innovative Panel testing system for IFD, Dynamiker has set up 6 core technology platforms, including: LAL products development platform, IFD polysaccharide Ag & Ab preparation platform, Immunology and automation platform, Microfluidics and POCT platform, Molecular diagnosis and MDR detection platform, and clinic transformation platform.
Dynamiker has successfully developed more than 20 IVD products and automation platform for IFD, 7 of which have filled the gap in the field in China and 6 panel testing products with international cutting edge standard. Dynamiker firstly presents Panel testing strategy for IFD, and is the only company who can supply all the products independently. Panel testing is easy to use and has reliable stability, high accuracy and strong anti-interference, which could achieve early & rapid diagnosis and dynamic monitoring of IFD. It could describe the infection situation and phase more precisely, and provide more accurate and reliable evidence for diagnosis and management of IFD.
As an important member of CHIFNET and partner of GAFFI (Global Action Fund for Fungal Infection), Dynamiker panel testing products have been serving tertiary hospitals in over 30 domestic provinces and 40 overseas countries with high praise. Strong international competitiveness and huge development potential make Dynamiker quickly grow into a leader in IFD diagnosis.
Following the principle “Technology is life”, Dynamiker puts forward innovative panel-testing scheme and establishes international industrialization, standardization, serialization technology platforms offering accurate reference evidence for clinic IFD diagnosis. Thinking globally and acting locally, Dynamiker has established strategic cooperation with overseas medical institutions and explored the global market via excellent products.
To become the global leading enterprise in early diagnosis of IFD, Dynamiker is preparing IPO, establishing cutting edge reference diagnostic laboratory for IFD, building more competitive R&D team, and building the whole eco industrial chain for IFD diagnosis and management.